Brief: Avenue Therapeutics Submitted Formal Dispute Resolution Request To FDA
01/09/2021 13:35
Sept 1 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS INC - ON AUGUST 31, SUBMITTED FORMAL
DISPUTE
RESOLUTION REQUEST TO FDA FOR CRL ISSUED BY FDA TO RELATED TO
ITS IV TRAMADOL NDA
* AVENUE THERAPEUTICS INC - SUBMISSION OF FDRR FOLLOWS
APPEAL
DENIED LETTER FROM OFFICE OF NEUROSCIENCE OF FDA
Source text for Eikon: [https://bit.ly/3zMzgIQ]
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary